Recruitment Strategies of a Decentralized Randomized Placebo Controlled Clinical Trial: The Canagliflozin Impact on Health Status, Quality of Life and Functional Status in Heart Failure (CHIEF-HF) Trial-Reference-Cited by-同舟云学术

Recruitment Strategies of a Decentralized Randomized Placebo Controlled Clinical Trial: The Canagliflozin Impact on Health Status, Quality of Life and Functional Status in Heart Failure (CHIEF-HF) Trial

Published:2023-06 Issue:6 Volume:29 Page:863-869
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

Nassif MICHAEL,BIRMINGHAM MARY C.,LANFEAR DAVID E.,GOLBUS JESSICA R.,GUPTA BHANU,FAWCETT CHRISTINA,HARRISON MARIA C.,SPERTUS JOHN A.

Funder

Janssen Scientific Affairs

National Institutes of Health

American Heart Association

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Heart disease and stroke statistics-2019 update: a report from the American Heart Association;Benjamin;Circulation,2019

2. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association;Heidenreich;Circ Heart Fail,2013

3. Epidemiology and risk profile of heart failure;Bui;Nat Rev Cardiol,2011

4. Effects of enalapril on mortality in severe congestive heart failure;N Engl J Med,1987

5. Angiotensin-neprilysin inhibition versus enalapril in heart failure;McMurray;N Engl J Med,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Trial Designs in Heart Failure: Using Digital Health Tools to Increase Pragmatism;Current Heart Failure Reports;2023-12-28

2. Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment Perspective;Value in Health;2023-12